News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 16 June 2026.

Net profit of Beryl Drugs rose 273.33% to Rs 0.56 crore in the quarter ended March 2026 as against Rs 0.15 crore during the previous quarter ended March 2025. Sales rose 29.22% to Rs 5.13 crore in the quarter ended March 2026 as against Rs 3.97 crore during the previous quarter ended March 2025.For the full year,net profit declined 27.59% to Rs 0.42 crore in the year ended March 2026 as against Rs 0.58 crore during the previous year ended March 2025. Sales declined 11.02% to Rs 18.82 crore in the year ended March 2026 as against Rs 21.15 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales5.133.97 29 18.8221.15 -11 OPM %25.9312.59 -12.8112.53 - PBDT1.260.42 200 2.072.12 -2 PBT0.860.10 760 0.580.87 -33 NP0.560.15 273 0.420.58 -28 Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 28 May 2026.

Beryl Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 11 May 2026.

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 1 April 2026.Powered by Capital Market - Live News